Gencurix Inc. (KOSDAQ:229000)
1,804.00
-11.00 (-0.61%)
Feb 18, 2025, 9:00 AM KST
Gencurix Revenue
Gencurix had revenue of 1.44B KRW in the quarter ending September 30, 2024, with 50.03% growth. This brings the company's revenue in the last twelve months to 3.39B, up 25.69% year-over-year. In the year 2023, Gencurix had annual revenue of 2.60B with 1.60% growth.
Revenue (ttm)
3.39B
Revenue Growth
+25.69%
P/S Ratio
8.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
31.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.60B | 40.83M | 1.60% |
Dec 31, 2022 | 2.56B | -487.46M | -16.00% |
Dec 31, 2021 | 3.05B | 1.47B | 93.83% |
Dec 31, 2020 | 1.57B | 1.44B | 1,050.64% |
Dec 31, 2019 | 136.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |